Author Barbara Glanemann, associate professor in small animal internal medicine at the RVC, said: “Our findings suggest commonly available laboratory changes early in treatment may help us all to better understand how an individual patient is responding and how high their risk is for developing adverse effects.
This can help us to individualise our treatment strategies.”
Author Barbara Glanemann, associate professor in small animal internal medicine at the RVC, said: “Our findings suggest commonly available laboratory changes early in treatment may help us all to better understand how an individual patient is responding and how high their risk is for developing adverse effects. This can help us to individualise our treatment strategies.”